Not All GLP-1 Receptor Agonists Are Alike: Real-World Evidence of Differential Endocrine and Dermatologic Safety. [PDF]
Lee N, Kim Y.
europepmc +1 more source
A Pharmacovigilance Analysis of Ocular Adverse Events Associated with GLP-1 Receptor Agonists. [PDF]
Virk A, Allison K.
europepmc +1 more source
Predictors and Characteristics of Hair Loss Among Users of GLP-1 Receptor Agonists: A Cross-Sectional Analysis. [PDF]
Argobi Y +6 more
europepmc +1 more source
GLP-1 receptor agonists for obesity: eligibility across 99 countries. [PDF]
Yoo SGK +46 more
europepmc +1 more source
Incretins (GLP-1 Receptor Agonists) and Polycystic Ovaries. [PDF]
Piazza MJ.
europepmc +1 more source
Current Insights and Future Directions on the Role of GLP-1 Receptor Agonists in Chronic Kidney Disease. [PDF]
Rajan K +3 more
europepmc +1 more source
Perioperative anesthesia management of GLP-1 receptor agonists: a systematic review of potential risks. [PDF]
Merhavy ZI +6 more
europepmc +1 more source
The potential role of GLP-1 receptor agonists in substance use disorders - a systematic review. [PDF]
Völker KM +3 more
europepmc +1 more source
GLP-1 Receptor Agonists and Noncardiometabolic Outcomes: An Umbrella Review of Meta-Analyses.
Yang K, Liu C, Guo Q, Li Y.
europepmc +1 more source
The effect of GLP-1 receptor agonists on renal outcomes: a systematic review and meta-analysis. [PDF]
Sasaki T +6 more
europepmc +1 more source

